TD Ameritrade Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
TD Ameritrade Investment Management's GILD Position: Q3 2023 in Review
TD Ameritrade Investment Management sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 2,952 shares — an estimated $228K sold.
TD Ameritrade Investment Management first reported a position in GILD in Q3 2018 and held it in 20 quarters. The position peaked at $809K in Q4 2021. 1,682 funds tracked by Wall St. Rank hold GILD as of Q3 2023.
- TD Ameritrade Investment Management reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
- TD Ameritrade Investment Management sold 2,952 Gilead Sciences shares in Q3 2023, an estimated $228K.
- TD Ameritrade Investment Management first reported a position in Gilead Sciences in Q3 2018 and held it in 20 quarters.
- TD Ameritrade Investment Management's Gilead Sciences position peaked at $809K in Q4 2021.
- 1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.
Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.